ES401603A1 - X-ray contrast agents - Google Patents
X-ray contrast agentsInfo
- Publication number
- ES401603A1 ES401603A1 ES401603A ES401603A ES401603A1 ES 401603 A1 ES401603 A1 ES 401603A1 ES 401603 A ES401603 A ES 401603A ES 401603 A ES401603 A ES 401603A ES 401603 A1 ES401603 A1 ES 401603A1
- Authority
- ES
- Spain
- Prior art keywords
- contrast agents
- ray contrast
- hydroxyacetamido
- acetamido
- physiologically compatible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Procedure for the preparation of X-ray contrast agents containing 3-acetamido-5-hydroxyacetamido-2,4,6-triiodobenzoic acid in the form of their water soluble salts with physiologically compatible bases, characterized in that per 100 ml of water 19.8 to 74.4 g of 3-acetamido-5-hydroxyacetamido-2,4,6-triiodobenzoic acid and the equivalent amount of one or more physiologically compatible bases are dissolved, the solution is filled in ampoules or multivials and sterilized . (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2118219A DE2118219C3 (en) | 1971-04-10 | 1971-04-10 | New X-ray contrast medium |
Publications (1)
Publication Number | Publication Date |
---|---|
ES401603A1 true ES401603A1 (en) | 1975-02-16 |
Family
ID=5804754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES401603A Expired ES401603A1 (en) | 1971-04-10 | 1972-04-08 | X-ray contrast agents |
Country Status (15)
Country | Link |
---|---|
AT (2) | AT318801B (en) |
AU (1) | AU463194B2 (en) |
BE (1) | BE781889A (en) |
CA (1) | CA987339A (en) |
CH (1) | CH574740A5 (en) |
DD (1) | DD95265A5 (en) |
DE (1) | DE2118219C3 (en) |
ES (1) | ES401603A1 (en) |
FR (1) | FR2132810B1 (en) |
GB (1) | GB1391843A (en) |
HU (1) | HU163446B (en) |
IL (1) | IL39167A (en) |
IT (1) | IT1048929B (en) |
NL (1) | NL7204789A (en) |
ZA (1) | ZA722396B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH641682A5 (en) * | 1978-10-05 | 1984-03-15 | Daeniker Felix | X-ray contrast medium |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3076024A (en) * | 1954-02-19 | 1963-01-29 | Sterling Drug Inc | Acylated 3, 5-diaminopolyhalobenzoic acids |
DE1129260B (en) * | 1961-05-12 | 1962-05-10 | Schering Ag | X-ray contrast media |
-
1971
- 1971-04-10 DE DE2118219A patent/DE2118219C3/en not_active Expired
-
1972
- 1972-03-30 IT IT22619/72A patent/IT1048929B/en active
- 1972-03-30 AU AU40633/72A patent/AU463194B2/en not_active Expired
- 1972-04-06 CH CH503472A patent/CH574740A5/xx not_active IP Right Cessation
- 1972-04-07 DD DD162148A patent/DD95265A5/xx unknown
- 1972-04-07 HU HUSCHE385*1A patent/HU163446B/hu unknown
- 1972-04-07 AT AT459173A patent/AT318801B/en not_active IP Right Cessation
- 1972-04-07 AT AT304472A patent/AT316523B/en not_active IP Right Cessation
- 1972-04-08 ES ES401603A patent/ES401603A1/en not_active Expired
- 1972-04-10 GB GB1634672A patent/GB1391843A/en not_active Expired
- 1972-04-10 BE BE781889A patent/BE781889A/en unknown
- 1972-04-10 CA CA139,316A patent/CA987339A/en not_active Expired
- 1972-04-10 ZA ZA722396A patent/ZA722396B/en unknown
- 1972-04-10 FR FR7212450A patent/FR2132810B1/fr not_active Expired
- 1972-04-10 IL IL39167A patent/IL39167A/en unknown
- 1972-04-10 NL NL7204789A patent/NL7204789A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HU163446B (en) | 1973-08-28 |
DE2118219A1 (en) | 1972-10-26 |
BE781889A (en) | 1972-10-10 |
FR2132810A1 (en) | 1972-11-24 |
DD95265A5 (en) | 1973-01-20 |
AT316523B (en) | 1974-07-10 |
DE2118219B2 (en) | 1980-07-03 |
GB1391843A (en) | 1975-04-23 |
CH574740A5 (en) | 1976-04-30 |
AU463194B2 (en) | 1975-07-02 |
ZA722396B (en) | 1972-12-27 |
DE2118219C3 (en) | 1981-07-16 |
FR2132810B1 (en) | 1975-03-14 |
IL39167A0 (en) | 1972-06-28 |
IT1048929B (en) | 1980-12-20 |
AT318801B (en) | 1974-11-25 |
IL39167A (en) | 1976-01-30 |
AU4063372A (en) | 1973-10-04 |
NL7204789A (en) | 1972-10-12 |
CA987339A (en) | 1976-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7903817L (en) | MORANOLIN DERIVATIVES | |
LV5801A4 (en) | Omeprazole added to the basal islet | |
IL40448A (en) | Bis-imidazolium(or benzimidazolium)salts,their preparation and pharmaceutical compositions containing them | |
FR2285857A1 (en) | MEDICAL CONTROL AGENT INTENDED TO BE ADMINISTERED BY INTRAVASCULAR ROUTE | |
CH541534A (en) | Preparation of glyoxylic acid | |
ES460743A1 (en) | Preserving liquid antacid medicinal formulations | |
ES370058A1 (en) | Antibiotic compositions | |
ES401603A1 (en) | X-ray contrast agents | |
BE786497A (en) | SUPERIOR APPROVED FOR RETINOIC ACID, ITS SALTS AND THEIR PREPARATION | |
EG10508A (en) | Method for preparation of 5-aryl 2,3-dihydro-2,2(or 3,3)dimethyl-5h-imidazo(2,1-a)isoindol-5-ols and 2(4,4(5,5)dimethyl-2-imidazolin-2-yl)bensophenone acid addition salts used as autidepressant drug | |
ES409333A1 (en) | Stabilization of aqueous solutions of bromine | |
ES387532A1 (en) | Procedure to manufacture a medicine. (Machine-translation by Google Translate, not legally binding) | |
BE792803A (en) | OPTICALLY ACTIVE 8,12-DIISOPROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING | |
ES436179A1 (en) | Physiological substances for intensifying the pharmacological effect of drugs | |
IL40623A (en) | 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them | |
ES294928A1 (en) | A procedure to prepare a liquid and stable composition of tetracycline (Machine-translation by Google Translate, not legally binding) | |
IL34468A0 (en) | Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them | |
ES393894A1 (en) | Piperidinemethyl ethers | |
GB1472816A (en) | Circulatory pharmaceutical compositions containing tetrahydroal stonine | |
FR2042290A1 (en) | Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders | |
ES370500A1 (en) | Procedure for the preparation of the hydracide. (Machine-translation by Google Translate, not legally binding) | |
GB1045969A (en) | Sodium betaine aspartate | |
IL36985A (en) | Pharmaceutical compositions containing acid addition salts of benzyl-(or beta-phenylethyl)-dimethylguanidine,certain such novel salts and their preparation | |
GB1354066A (en) | ||
SE7707367L (en) | WAY TO PRODUCE NEW GLYCINAMIDES |